We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current 0A8E market cap is 0. The company's latest EPS is USD -0.4507 and P/E is -6.79.
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 49.59M | 110.25M | 163.91M |
Operating Income | -115.16M | -81.94M | -44.01M |
Net Income | -122.73M | -94.66M | -62.26M |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 304.36M | 344.52M | 322.6M |
Total Liabilities | 209.13M | 299.34M | 329.38M |
Total Equity | 95.23M | 45.19M | -6.78M |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Operating | -95.54M | -102.89M | -47.02M |
Investing | 97.96M | 34.46M | -6M |
Financing | 27.25M | 127.47M | -1.61M |
Market Cap | 0 |
Price to Earnings Ratio | -6.79 |
Price to Sales Ratio | 2.58 |
Price to Cash Ratio | 6.27 |
Price to Book Ratio | -62.32 |
Dividend Yield | - |
Shares Outstanding | 138.13M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0 (0%) |
Company Name | Xeris Biopharma Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.xerispharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions